Beta-lactam Intermittent Versus Continuous Infusion and Combination Antibiotic Therapy in Sepsis

NCT05681442 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

600

Enrollment

OTHER

Sponsor class

Conditions

Sepsis

Interventions

DRUG: continuous pivotal βL-AB
DRUG: intermittent pivotal βL-AB
DRUG: AG infusion most 1 dose
DRUG: AG infusion for 5 days

Sponsor

Assistance Publique - Hôpitaux de Paris